Intracellular Th Stock Total Debt
| ITCI Stock | USD 126.20 0.06 0.05% |
Intracellular Th fundamentals help investors to digest information that contributes to Intracellular's financial success or failures. It also enables traders to predict the movement of Intracellular Stock. The fundamental analysis module provides a way to measure Intracellular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intracellular stock.
The Intracellular's current Total Debt To Capitalization is estimated to increase to 0.06. Intracellular | Total Debt |
Intracellular Th Company Total Debt Analysis
Intracellular's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Intracellular Total Debt | 16.94 M |
Most of Intracellular's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intracellular Th is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intracellular Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Intracellular is extremely important. It helps to project a fair market value of Intracellular Stock properly, considering its historical fundamentals such as Total Debt. Since Intracellular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intracellular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intracellular's interrelated accounts and indicators.
Click cells to compare fundamentals
Intracellular Total Debt Historical Pattern
Today, most investors in Intracellular Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intracellular's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Intracellular total debt as a starting point in their analysis.
Intracellular Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Intracellular Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Intracellular Th has a Total Debt of 16.94 M. This is 99.38% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 99.68% higher than that of the company.
Intracellular Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intracellular's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics of similar companies.Intracellular is currently under evaluation in total debt category among its peers.
Intracellular ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Intracellular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Intracellular's managers, analysts, and investors.Environmental | Governance | Social |
Intracellular Institutional Holders
Institutional Holdings refers to the ownership stake in Intracellular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intracellular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intracellular's value.| Shares | Clearbridge Advisors, Llc | 2024-09-30 | 1.7 M | Geode Capital Management, Llc | 2024-09-30 | 1.7 M | Perceptive Advisors Llc | 1.6 M | Pictet Asset Manangement Sa | 2024-09-30 | 1.6 M | Deep Track Capital, Lp | 2024-09-30 | 1.6 M | Suvretta Capital Management, Llc | 2024-09-30 | 1.4 M | Gw&k Investment Management, Llc | 2024-09-30 | 1.4 M | Holocene Advisors, Lp | 2024-09-30 | 1.4 M | Alliancebernstein L.p. | 2024-09-30 | 1.2 M | Fmr Inc | 2024-09-30 | 11.1 M | Vanguard Group Inc | 2024-09-30 | 9.6 M |
Intracellular Fundamentals
| Return On Equity | -0.099 | ||||
| Return On Asset | -0.0745 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 12.43 B | ||||
| Shares Outstanding | 106.24 M | ||||
| Shares Owned By Insiders | 2.33 % | ||||
| Shares Owned By Institutions | 96.05 % | ||||
| Number Of Shares Shorted | 1.98 M | ||||
| Price To Earning | (6.56) X | ||||
| Price To Book | 11.72 X | ||||
| Price To Sales | 21.85 X | ||||
| Revenue | 464.37 M | ||||
| Gross Profit | 349.86 M | ||||
| EBITDA | (158.85 M) | ||||
| Net Income | (139.67 M) | ||||
| Cash And Equivalents | 628.74 M | ||||
| Cash Per Share | 6.64 X | ||||
| Total Debt | 16.94 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 9.81 X | ||||
| Book Value Per Share | 10.80 X | ||||
| Cash Flow From Operations | (124.2 M) | ||||
| Short Ratio | 4.22 X | ||||
| Earnings Per Share | (0.87) X | ||||
| Target Price | 121.36 | ||||
| Number Of Employees | 610 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 13.41 B | ||||
| Total Asset | 728.29 M | ||||
| Retained Earnings | (1.62 B) | ||||
| Working Capital | 544.25 M | ||||
| Current Asset | 541.82 M | ||||
| Current Liabilities | 140.69 M | ||||
| Net Asset | 728.29 M |
About Intracellular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intracellular Th's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular Th based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Intracellular Piotroski F Score and Intracellular Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share | Quarterly Revenue Growth 0.39 | Return On Assets | Return On Equity |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.